Form D - Notice of Exempt Offering of Securities:
SEC Accession No. 0001501989-15-000001
Filing Date
2015-01-06
Accepted
2015-01-06 13:38:40
Documents
1
Effectiveness Date
2015-01-06
Items
Item 06b:

Document Format Files

Seq Description Document Type Size
1 primary_doc.html D  
1 primary_doc.xml D 9043
  Complete submission text file 0001501989-15-000001.txt   10123
Mailing Address 650 GATEWAY BLVD. SUITE 125 SOUTH SAN FRANCISCO CA 94080
Business Address 650 GATEWAY BLVD. SUITE 125 SOUTH SAN FRANCISCO CA 94080 650.515.3185
CytomX Therapeutics, Inc. (Filer) CIK: 0001501989 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: D | Act: 33 | File No.: 021-231506 | Film No.: 15509183